Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: Histological and clinical study results

British Journal of Dermatology

Volumn 165, Issue 5, 2011, Pages 1101-1108

  Stockfleth, E ^a   Kerl, H ^b   Zwingers, T ^c   Willers, C ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Universitatsklinik fur Dermatologie und Venerologie   (Austria)

^c Fa Estimate GmbH Augsburg   (Germany)

^d Almirall Hermal GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIKERALL; DICLOFENAC; FLUOROURACIL; HYALURONIC ACID; PLACEBO; SALICYLIC ACID; UNCLASSIFIED DRUG; KERATOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACTINIC KERATOSIS; ADULT; AGED; APPLICATION SITE BURNING; APPLICATION SITE INFLAMMATION; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; ARTICLE; BENIGN TUMOR; CLEARANCE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FACE; FEMALE; FOREHEAD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; INFESTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SKIN BIOPSY; SKIN DEFECT; SKIN DISEASE; TREATMENT RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FEMALE; FLUOROURACIL; HUMANS; HYALURONIC ACID; KERATOLYTIC AGENTS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; SALICYLIC ACID; TREATMENT OUTCOME;

EID: 84856401179     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10387.x     Document Type: Article

References (22)

1. Ackerman AB. Solar keratosis is squamous cell carcinoma. Arch Dermatol 2003; 139:1216-17. (Pubitemid 37128391)
2. Berman B, Amini S, Valins W et al. Pharmacotherapy of actinic keratosis. Expert Opin Pharmacother 2009; 10:3015-31.
3. Stockfleth E, Kerl H. Guideline subcommittee of the European dermatology forum. Guidelines for the management of actinic keratoses. Eur J Dermatol 2006; 16:599-606.
4. Goldberg LH, Mamelak AJ. Review of actinic keratosis. Part I: etiology, epidemiology and clinical presentation. J Drugs Dermatol 2010; 9:1125-32.
5. Brash DE, Ziegler A, Jonason AS et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor protection. J Investig Dermatol Symp Proc 1996; 1:136-42. (Pubitemid 126759356)
6. Rivers JK, Arlette J, Shear N et al. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol 2002; 146:94-100. (Pubitemid 34158414)
7. Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol 2003; 44:40-5.
8. Wolf JE Jr, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 2001; 40:709-13. (Pubitemid 34023642)
9. Jorizzo J, Steward D, Bucko A et al. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. Cutis 2002; 10:335-9. (Pubitemid 41757441)
10. Levy S, Furst K, Chern W. A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation. Clin Ther 2001; 23:901-7. (Pubitemid 32554571)
11. Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5% fluorouracil gel and 5% fluorouracil gel applied to each side of the face in patients with actinic keratosis. Clin Ther 2002; 24:990-1000. (Pubitemid 34734743)
12. Gupta AK. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation. Cutis 2002; 70:30-6.
13. Lawrence N, Cox SE, Cockerell CJ et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic vs. 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995; 131:176-81.
14. Schlaak M, Simon JC. Topical treatment of actinic keratoses with low-dose 5-fluorouracil in combination with salicylic acid - pilot study. J Dtsch Dermatol Ges 2010; 8:174-8. [Article in English, German].
15. Olsen EA, Abernethy ML, Kulp-Shorten C et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratosis on the head and neck. J Am Acad Dermatol 1991; 24:738-43.
16. Pathak MA, Fitzpatrick TB, Greiter F et al. Preventive treatment of sun burn, dermatoheliosis, and skin cancer with sun-protective agents in dermatology in general medicine. In: Dermatology in General Medicine (Fitzpatrick TB, Eisen AZ, Wolff K et al., eds), 3rd edn. New York: McGraw-Hill Book Company, 1987; 1507-22.
17. Röwert-Huber J, Patel MJ, Forschner T et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156 (Suppl. 3):8-12. (Pubitemid 46632512)
18. Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials. Int J Dermatol 2009; 48:453-63.
19. Nelson C, Rigel D, Smith S et al. Phase IV, open-label assessment of the treatment of actinic keratosis with 3% diclofenac sodium topical gel (Solaraze™). J Drugs Dermatol 2004; 3:401-7.
20. Krawtchenko N, Roewert-Huber J, Ulrich M et al. A randomized study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryotherapy in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157 (Suppl. 2):34-40. (Pubitemid 350179628)
21. Gerritsen MJ, Smits T, Kleinpenning MM et al. Pretreatment to enhance protoporphyrin IX accumulation in photodynamic therapy. Dermatology 2009; 218:193-202.
22. Lin AN, Nakatsui T. Salicylic acid revisited. Int J Dermatol 1998; 37:335-42. (Pubitemid 28231305)